Skip Nav Destination
You do not currently have access to this content.

A recent workshop discussed characteristics of nonprescription drugs that may be considered “candy-like,” potentially resulting in inadvertent overdose in young children.
Pediatricians encouraged to join FDA workshops on pediatric drug development
September 1, 2024
Article type:
FDA Update
Topics:
Sign in
Don't already have an account? Register
Purchased this content as a guest? Enter your email address to restore access.
Please enter valid email address.
Pay-Per-View Access
$35.00